NEIS JOHN 4
4 · Cellectar Biosciences, Inc. · Filed Oct 15, 2018
Insider Transaction Report
Form 4
NEIS JOHN
Director
Transactions
- Award
Stock option (right to buy)
2018-10-12+13,000→ 13,000 totalExercise: $2.61Exp: 2028-10-12→ Common Stock (13,000 underlying)
Footnotes (1)
- [F1]This option grant was divided into a definitive grant of 6,150 shares, which vest in equal monthly installments over a seven month period from the grant date, and a contingent grant of 6,850 shares, which are subject to the following conditions: (i) approval by Cellectar's stockholders of an increase in shares available under the Amended and Restated 2015 Stock Incentive Plan at the Corporation's 2019 annual meeting of stockholders or other special meeting of stockholders called for such purpose; and (ii) to the extent stockholder approval is received, the contingent grant shall vest immediately upon such stockholder approval.